Graft Versus Host Disease: Clinical Trials

2 trials for Graft Versus Host Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Graft Versus Host Disease: new trials by email Literature Review of Graft Versus Host Disease trials Research Report on Graft Versus Host Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor
Prograf, Methotrexate, Cyclosporine - Graft Versus Host Disease
Phase 4CompletedAstellas Pharma Korea, Inc.392008-02-012016-03-01
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
anti-thymocyte globulin, filgrastim, cyclophosphamide - Anemia, Graft Versus Host Disease
Phase 4CompletedUniversity of Maryland, Baltimore451998-09-012019-10-17

Narrower conditions

Graft vs Host Disease (2)  ·  Anemia (1)  ·  Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Hodgkin Disease (1)  ·  Leukemia (1)  ·  Leukemia, Basophilic, Acute (1)  ·  Leukemia, Eosinophilic, Acute (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Leukemia, Myelomonocytic, Acute (1)

Broader conditions

Immune System Diseases (2)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Carcinogenesis (1)  ·  Cardiovascular Diseases (1)  ·  Cell Transformation, Neoplastic (1)  ·  Chronic Disease (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Herpesviridae Infections (1)

Interventions

Antilymphocyte Serum (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Filgrastim (1)  ·  Methotrexate (1)  ·  Radiotherapy (1)  ·  Tacrolimus (1)  ·  Thiotepa (1)

Sponsors

Astellas Pharma Korea, Inc. (1)  ·  University of Maryland, Baltimore (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Barry R. Meisenberg, MD (1)